Education
About Us
Working with TipRanks
Follow Us
Alterity Therapeutics Ltd. (PRNAF)
:PRNAF
RESEARCH TOOLSreports
Total Valuation
Alterity Therapeutics Ltd. has a market cap or net worth of $58.84M. The enterprise value is ―.
Market Cap$58.84M
Enterprise Value―
Share Statistics
Alterity Therapeutics Ltd. has 9,127,371,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding9,127,371,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Alterity Therapeutics Ltd.’s return on equity (ROE) is -1.39 and return on invested capital (ROIC) is -140.78%.
Return on Equity (ROE)-1.39
Return on Assets (ROA)-0.99
Return on Invested Capital (ROIC)-140.78%
Return on Capital Employed (ROCE)-1.42
Revenue Per Employee401.93K
Profits Per Employee-1.91M
Employee Count10
Asset Turnover0.21
Inventory Turnover214.30K
Valuation Ratios
The current PE Ratio of Alterity Therapeutics Ltd. is -0.95. Alterity Therapeutics Ltd.’s PEG ratio is -0.10.
PE Ratio-0.95
PS Ratio0.00
PB Ratio6.58
Price to Fair Value1.32
Price to FCF-5.54
Price to Operating Cash Flow-3.11
PEG Ratio-0.10
Income Statement
In the last 12 months, Alterity Therapeutics Ltd. had revenue of 4.02M and earned -19.12M in profits. Earnings per share was -0.01.
Revenue4.02M
Gross Profit3.80M
Operating Income-19.60M
Pretax Income-19.08M
Net Income-19.12M
EBITDA-19.57M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -16.47M and capital expenditures 278.00, giving a free cash flow of -16.47M billion.
Operating Cash Flow-16.47M
Free Cash Flow-16.47M
Free Cash Flow per Share>-0.01
Dividends & Yields
Alterity Therapeutics Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.67
52-Week Price Change0.00%
50-Day Moving Average0.01
200-Day Moving Average―
Relative Strength Index (RSI)100.00
Average Volume (3m)70.00
Important Dates
Alterity Therapeutics Ltd. upcoming earnings date is Feb 26, 2026, TBA Not Confirmed.
Last Earnings DateFeb 28, 2025
Next Earnings DateFeb 26, 2026
Ex-Dividend Date―
Financial Position
Alterity Therapeutics Ltd. as a current ratio of 3.54, with Debt / Equity ratio of 1.36%
Current Ratio3.54
Quick Ratio3.54
Debt to Market Cap0.00
Net Debt to EBITDA0.64
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Alterity Therapeutics Ltd. has paid 46.09K in taxes.
Income Tax46.09K
Effective Tax Rate>-0.01
Enterprise Valuation
Alterity Therapeutics Ltd. EV to EBITDA ratio is -0.29, with an EV/FCF ratio of -0.46.
EV to Sales1.44
EV to EBITDA-0.29
EV to Free Cash Flow-0.46
EV to Operating Cash Flow-0.46
Balance Sheet
Alterity Therapeutics Ltd. has $4.54M in cash and marketable securities with AU$105.83K in debt, giving a net cash position of -$4.43M billion.
Cash & Marketable Securities$4.54M
Total DebtAU$105.83K
Net Cash-$4.43M
Net Cash Per Share>-$0.01
Tangible Book Value Per Share<$0.01
Margins
Gross margin is 96.32%, with operating margin of -487.69%, and net profit margin of -475.79%.
Gross Margin96.32%
Operating Margin-487.69%
Pretax Margin-474.65%
Net Profit Margin-475.79%
EBITDA Margin-486.94%
EBIT Margin-487.82%
Analyst Forecast
The average price target for Alterity Therapeutics Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―